CD
MDT icon

Chapin Davis’s Medtronic MDT Stock Holding History

Chapin Davis’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$305K Buy
3,898
+1,151
+42% +$92.9K 0.05% 192
2026
Q1 		$238K Buy
+2,747
New +$263K 0.05% 229
2023
Q3 		– Sell
-2,540
Closed -$224K – 222
2023
Q2 		$224K Sell
2,540
-2
-0.1% -$172 0.11% 179
2023
Q1 		$205K Buy
+2,542
New +$207K 0.11% 193

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Chapin Davis's MDT Position: Q2 2026 in Review

Chapin Davis increased its Medtronic (MDT) stake by 42% in Q2 2026, buying an estimated $92.9K and bringing the position to 3,898 shares worth $305K. The position accounts for 0.05% of the portfolio, ranked #192.

Chapin Davis first reported a position in MDT in Q1 2023 and has held it in 4 quarters since. 2,132 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Chapin Davis held 3,898 shares of Medtronic worth $305K as of Q2 2026.
  • Chapin Davis bought 1,151 Medtronic shares in Q2 2026, an estimated $92.9K.
  • Medtronic made up 0.05% of Chapin Davis's portfolio in Q2 2026, its #192 holding.
  • Chapin Davis first reported a position in Medtronic in Q1 2023 and has held it in 4 quarters since.
  • 2,132 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Chapin Davis's 13F filing for Q2 2026, filed 7 Jul 2026.